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Abstract: 52 53
Pain is a complex process that involves both detection in the peripheral nervous system 54 and perception in the central nervous system. Individual-to-individual differences in pain 55 are well-documented, but not well-understood. Here we capitalized on inherited 56 erythromelalgia (IEM), a well-characterized human genetic model of chronic pain, and 57 studied a unique family containing related IEM subjects with the same disease-causing 58 Nav1.7 mutation, which is known to make dorsal root ganglion (DRG) neurons 59
hyperexcitable, but different pain profiles (affected son with severe pain, affected 60 mother with moderate pain and an unaffected father). We show, first, that at least in 61 some cases, relative sensitivity to pain can be modeled in subject-specific iPSC-derived 62 sensory neurons in vitro; second, that in some cases, mechanisms operating in 63 peripheral sensory neurons contribute to inter-individual differences in pain; and third, 64 using Whole Exome Sequencing (WES) and dynamic clamp we show that it is possible 65 to pinpoint a specific variant of another gene, KCNQ in this particular kindred, that 66 modulates the excitability of iPSC-derived sensory neurons in this family. While different 67 gene variants may modulate DRG neuron excitability and thereby contribute to inter-68 individual differences in pain in other families, this study shows that subject-specific 69 iPSCs can be used to model inter-individual differences in pain. We further provide 70 proof-of-principle that iPSCs, WES, and dynamic clamp can be used to investigate 71 peripheral mechanisms and pinpoint specific gene variants that modulate pain signaling 72 and contribute to inter-individual differences in pain. 73 74 75
Materials and Methods 144
Generation of induced pluripotent stem cells (iPSCs) 145 iPSCs were generated from the blood samples of two IEM subjects (mother (P301) and 146 son (P300) carrying Nav1.7-S241T mutation) and an unaffected individual (father 147 (P303)) using CytoTune-iPS 2.0 Sendai Reprogramming Kit (ThermoFisher Scientific) 148 according to the manufacturer protocol. Cells were screened for pluripotent stem cell 149 markers and tested for normal karyotype. iPSCs were cultured for at least 10 150 generations before the start of differentiation into sensory neurons (iPSC-SNs). The 151 study was approved by the Yale Human Investigation Committee. 152
Differentiation of iPSC into sensory neurons 153
Differentiation was initiated using a modified Chambers protocol using LSB and 3i 154 inhibitors (Chambers et 2h at room temperature in PBS-T. Images were acquired using a Nikon C1 confocal 166 microscope (Nikon). 167
Multi Electrode Array Recordings 168
Multi Electrode Array (MEA) experiments were carried out with a multi-well MEA system 169 (Maestro, Axion Biosystems) according to our recently developed protocol (Yang et al., 170 2016) . Briefly, iPSC-SNs were dissociated and cultured on MEA plates, maintained at 171 37ºC in a 5% CO 2 incubator. A 12-well recording plate was used, embedded with a total 172 of 768 electrodes. For each experiment, three wells (with ~192 available electrodes for 173 recording) were used to assess iPSC-SNs derived from P301 (mother), P300 (son) and 174
P303 (father). 175
Whole-cell current-clamp electrophysiology 176
Whole-cell current-clamp recordings were obtained for head-to-head comparisons from 177 iPSC-SNs from paired differentiations prepared contemporaneously and processed in 178 parallel by the same technician and studied by the same electrophysiologist. 179
Recordings were amplified using an Axon MultiClamp 700B amplifier. Data were 180 digitized via an analogue to digital converter Digidata 1440a and stored on a personal 181 computer using pClamp 10.4 software, which was also used to define and execute 182 protocols. The data were filtered at 5 kHz and acquired at 50 kHz. Electrodes used for 183 the recordings had resistance of < 1.5 MΩ when filled with the internal solution, which 184 consisted of (mM): KCl 140; HEPES, 5; EGTA, 0.5; Mg-ATP, 3; Dextrose 20; pH 7.3, 185 295-300 mOsm. iPSC-SNs were continuously perfused with external recording solution 186 containing (mM): NaCl, 140; KCl, 3; HEPES-NaOH, 10; MgCl2, 2; CaCl2, 2; Dextrose, 187 15; pH 7.3, ~320 mOsm. 188
Whole exome sequencing and analysis 189
Whole exome sequencing (WES) was performed at Yale Center for Genome Analysis 190 following a previously published protocol (Zaidi et al., 2013; Jin et al., 2017) . Three 191 subjects were included for sequencing analysis: proband carrying Nav1.7-S241T 192 mutation, proband's mother carrying Nav1.7-S241T mutation, and proband's unaffected 193 father. The obtained reads were filtered and trimmed for quality and aligned to the hg19 194 version of the human genome (GRCh37) using aligner (BWA-MEM). From the aligned 195 reads, we used variant caller (GATK) to call the variants from each sample. We 196 extracted the significant variants based on genotyping quality score and coverage of the 197 reference and alternative base (the criteria are at least 3 reads with alternative base, 198
and at least 20% of coverage is alternative base). All the variants that passed the filter 199
were then collected across all the samples using custom-built python scripts. 
RT-PCR and sequencing 205
RNA was isolated from iPSC-SNs from P300, P301 and P303 using RNeasy plus kit 206 (Qiagen Cat#74134) according to the manufacturer's protocol. RNA concentration was 207 measured on a Nanodrop, and total RNA (100 ng) was used to generate cDNA using 208
Bio-Rad iScript Reverse Transcription Supermix (Cat#170-8841). One ml cDNA was 209 used as a template for PCR amplification in a final volume of 50 ml. High Fidelity, 210
AccuPrime Taq DNA Polymerase (ThermoFisher Cat#12346-086) was used for 211 amplification. At least one of the primers crosses an exon-intron boundary to distinguish 212 cDNA products from potential genomic DNA contamination. 213
Thermal cycling was initiated at 94°C for 2 minutes followed by 35 cycles of 30 s at 214 94°C, annealing for 30 s at 55°C for Nav1.7 (60°C for Kv7.2), and an extension for 60 s 215 at 68°C. Because of high GC content, PCR was performed with 6% DMSO for Kv7.2. 216
The following primers were used: 5'-ATCACGGACAAGGACCGCACC-3' and 5'-217 TCCTGCCGCAGGAACTCCATG-3' generating a 512 bp fragment for Kv7.2; 5'-218 TGCAAGAGGCTTCTGTGTAGG-3' and 5'-GCTCGTGTAGCCATAATCAGG-3' 219 generating a 514 bp fragment for Nav1.7. The identity of the amplicon was verified by 220
Sanger sequencing using the purified PCR product (PCR clean-up, Gel extraction kit, 221
Macherey-Nagel Cat# 740609.50), and the same forward and reverse primers that were 222 used for PCR amplification. Sequencing was done at the Keck DNA Sequencing facility 223 at Yale University. 224
Perforated-patch I M recordings in iPSC-SNs 225
Recordings were obtained using EPC-10 amplifier and the PatchMaster program (HEKA 226 Elecktronik). Data were sampled at 4 kHz and filtered at 2.9 kHz low-pass Bessel filter. The gating variable for I M is described using a Hodgkin-Huxley differential equation 273 dn/dt = α n (1 -n) -β n n, where n is the channel activation variable and α(β) is forward 274 (reverse) rate constants, respectively. I M steady-state parameters and kinetics obtained 275 from electrophysiological recordings were converted into rate constants at respective 276 voltages using the equations α = n/τ, β = (1 -n)/τ. Liquid junction potentials (+8.2 mV) 277 were adjusted for all parameters. Reaction rate constants were fitted with a Boltzmann 278 equation and converted into steady-state activation variable and time constant 279 according to n = α/(α+ β) and τ = 1/(α+ β). WT and T730A I M models were calculated in 280 a 28-pF equipotential sphere of 1 μF/cm 2 capacitance with a conductance density of 281 0.00014 S/cm2. 282
The following rate constants were used for P300 (homozygous KCNQ2-WT) 283
Kv7.2 channel model: 284 To minimize potential variations during the recordings, iPSC-SNs from all three subjects 299 were differentiated on the same day with same reagents. iPSC-SNs were always plated 300 on MEA plates by the same investigator. A spike detection criterion of >6 standard 301 deviations above background signals was used to separate monophasic and biphasic 302 action potential spikes from noise. We defined active electrodes as registering >1 303 recorded spike over a 200 s period (Yang et al., 2016) . MEA data were analyzed using 304
Axion Integrated Studio AxIS2.1 (Axion Biosystems) and NeuroExplorer (Nex 305 Technologies) (Yang et al., 2017) . 306
To assess the firing properties under different temperatures, the precise 307 temperature control of the MEA system was utilized, which enables continuous 308 monitoring of neuronal firing during temperature ramps. iPSC-SNs from P301, P300 and 309 P303 were plated on the same MEA plate for the temperature ramp study, and 310 assessed by an investigator blinded to the genotype. Three different temperatures 311 (33ºC, 37ºC and 40ºC) were used during the study, and each temperature was 312 maintained for 7-10 min to allow analysis of steady-state neuronal firing at each 313 condition. 314
Whole-cell current-clamp 315
Only iPSC-SNs with stable membrane potential were chosen for analysis. Resting 316 membrane potential was determined immediately after switching into current-clamp 317 mode as the mean membrane voltage in the absence of current stimulation. Set pre-318 stimulus membrane potentials were established by manual injection of bias currents of 319 appropriate amplitudes for the experiments. Current threshold was defined as the 320 minimum amount of current necessary to trigger an Action Potential (AP) and was 321 determined by injecting depolarizing 200 ms current steps in 5 pA increments until an 322 AP was triggered. In order to assess the firing properties, incremental depolarizing 500 323 ms current steps up to 500 pA were applied. The elicited APs were counted and plotted 324 against the current injection intensity. Recorded data were processed offline using 325 pClamp v10.6, Origin 2017 and Excel. pain profiles between individuals may reflect differences in processing at multiple levels 345 including higher CNS levels, we reasoned that differences in peripheral neurons might 346 also play a role, particularly in individuals with pain of peripheral origin, such as those 347 (e.g., P300 and P301) who carry a gain-of-function mutation in Na V 1.7 -a channel 348 which is mainly expressed in peripheral sensory neurons where it confers 349 hyperexcitability on them. To assess whether differences in pain profiles might be 350 modeled in an in vitro system containing only their peripheral neurons, we derived 351 iPSC-SNs from the affected son (P300) and mother (P301), as well as the unaffected 352 father (P303) using a differentiation protocol which produces pain-sensing sensory- RT-PCR and shows that both P300 and P301 iPSC-SNs produce both wild-type and 360 S241T mutant transcripts, while samples from P303 produced only wild-type (WT) 361 transcripts (Figure 1-1) . 362
We first studied the excitability of these iPSC-SNs using multi-electrode arrays 363 (MEA), a non-invasive, high-throughput, extracellular recording approach, that can 364 assess the excitability of intact neurons (Spira and Hai, 2013) . MEA is capable of 365 accurately recording action potential (AP) firing of neurons as temperature is altered. 366
Because pain in individuals with IEM (including subjects P300 and P301) is triggered by 367 warmth, we assessed the firing of these intact iPSC-SNs at three different 368 temperatures: skin temperature (33°C), core body temperature (37°C), and nonnoxious 369 warmth (40°C). Neurons from both P300 and P301 displayed temperature-induced 370 increases in firing, as reflected by heat maps (Figure 1D ). Elevating the temperature 371 increased both the mean firing frequency and number of neurons firing APs without 372 electrical stimulation, with neurons from P300 and P301, which carry the S241T 373 mutation, more excitable than these from P303, the unaffected father who does not 374 carry the mutation (Figure 1D-F) . Indeed, we did not observe any firing from iPSC-SNs 375 derived from P303 at frequencies above 0.2 Hz, even at 40°C. Notably, while the 376 significant effect of the mutation on mean firing rate (F = 24.7, p = 0.00002; one-way 377 repeated measures ANOVA; 6 independent differentiations from 2 independent clones 378 for each line) and on number of active electrodes (F = 192, p < 0.0001; one-way 379 repeated measures ANOVA) was expected, we also observed significant differences in 380 excitability of iPSC-SNs between P300 and P301 ( Figure 1F) , who both carry the same 381 Na V 1.7-S241T mutation but reported differences in their pain. Subject-specific iPSC-SNs from P300 and P301 display differences in membrane 395 excitability that parallel differences in pain profiles 396 A spectrum of differences in membrane properties might contribute to inter-397 individual differences in activity of DRG neurons in different kindreds. To extend the 398 findings from the MEA assay to the level of membrane excitability in the family under 399 study, we used whole-cell patch-clamp for a head-to-head comparison of iPSC-SNs 400 from P300, P301 and P303, from differentiations prepared contemporaneously and 401 processed in parallel. These experiments revealed pronounced excitability differences 402 between iPSC-SNs from the three subjects. We assessed four major parameters that 403 reflect the levels of neuronal excitability: induced firing, percentage of neurons firing 404 repetitively, current threshold, and resting member potential (RMP). For all these four 405 parameters, we observed very clear and consistent differences in excitability between 406 iPSC-SNs from P300, P301 and P303 that again paralleled differences in pain profiles. 407
In response to graded suprathreshold 500 ms depolarizing stimuli, across the entire 408 current injection range, neurons derived from P300 fired the highest number of experiments we studied the current threshold and firing rate of individual iPSC-SNs at 436 RMP before either depolarizing (P301) or hyperpolarizing (P300) the membrane 437 potential of each given neuron by 4 mV. We found that depolarizing neurons derived 438 from P301 by 4 mV resulted in a 25 ± 4% decrease in the current threshold, whereas 439 hyperpolarizing neurons derived from P300 caused a 24 ± 5% increase in current 440 threshold ( Figure 3A-B) . Consequently, there was not a significant difference in current 441 threshold between P300 and P301 when the difference in RMP was removed by 442 depolarizing neurons from P301 by 4 mV (Figure 3C ; P300 = 35 ± 4 pA, n = 12; P301 = 443 36 ± 4 pA, n = 10; t = 0.1, p = 0.9, two-tailed unpaired t test) or by hyperpolarizing 444 neurons from P300 by 4 mV (Figure 3D ; P300 = 51 ± 6 pA, n = 12; P301 = 45 ± 5 pA; t 445 = 0.1, p = 0.9, two-tailed unpaired t test). Similarly, using the same paradigm to study 446 the firing rate of both groups of iPSC-SNs, we found that there was no significant 447 difference in firing rate between iPSC-SNs derived from P300 and P301 when studied 448 Because subjects P300 (severe pain) and P301 (moderate pain) share the same 458 Na V 1.7-S241T mutation, we hypothesized that additional genetic variations might 459 contribute to the difference in excitability between iPSC-SNs from P300 and P301. To 460 identify these potential modifiers in the family under study, we performed WES on 461 samples from this family and filtered the resulting variants according to their expression 462 in DRG neurons using Ingenuity Pathway Analysis (IPA, Build 470319M Version 463 43605602), a manually-curated knowledge database created from the peer-reviewed 464 biomedical literature. WES confirmed the S241T mutation in both P300 and P301 but 465 not in the P303. 466
The WES analysis identified 90 variants in P300 and P301 in genes known to be 467 expressed in DRG neurons (9 in P300 and 81 in P301) ( Figure 4A; Figure 4-1) . Since 468 we found significant differences in excitability between iPSC-SNs from P300 and P301 469 (Figure 2A-E) , we interrogated specific Gene Ontology processes and functions related 470 to neuronal excitability ('Excitation of neuron' and 'Neuronal Action Potential'). These 471 terms identified a variant in KCNQ2, the gene which encodes potassium channel Kv7.2, 472 in subject P301 (mother), but not in P300 (son; Figure 4B) . Notably, Kv7. mV. Indeed, extrapolation of our experimental data suggests a maximum current close 532 to 400 pA (Figure 5-1) , corresponding to ~8 nS maximum conductance. Hence, we 533 examined the contribution of Kv7.2-T730A I M to changes in RMP and current threshold 534 in P301 iPSC-SNs, by substituting Kv7.2-T730A I M , which we expect to be 50% of the 535 total current, with 50% WT I M conductance, using dynamic clamp and implementing 4, 536 6, 8 and 10 nS maximum conductance levels. The effect of Kv7.2-T730A I M on RMP 537 was measured, as shown in Figure 5C . Substituting the Kv7.2-T730A I M with an 538 equivalent amount of WT conductance, caused RMP depolarization in an incremental 539 fashion with increasing amounts of overall conductance. The average values are 540 presented in Figure 5D and reveal depolarization of 2.2 ± 0.3 mV with 4 nS 541 conductance (t = 7, p = 0.001, two-tailed paired t-test, n = 9), 3.6 ± 0.6 mV with 6 nS 542 conductance (t = 6, p = 0.005, two-tailed paired t-test, n = 5), 4.6 ± 0.6 mV with 8 nS 543 conductance (t = 7, p = 0.002, two-tailed paired t-test, n = 5) and 6.4 ± 1 with 10 nS 544 conductance (t = 6, p = 0.004, two-tailed paired t-test, n = 5). Spontaneous firing was 545 observed in two additional iPSC-SNs at conductances greater than 4 nS (example trace 546 in figure 5E ) and 6 nS (trace not shown). 547
We also assessed the effect of the Kv7.2-T730A variant on current threshold of 548 iPSC-SNs from P301. The reduction in current threshold from baseline (dynamic clamp 549 off) is presented in Figure 5F for individual iPSC-SNs (grey symbols) and the average 550 (blue symbols) for the same range of conductances of 4 -10 nS. Substitution of 50% 551
Kv7.2-T730A I M with 50% WT I M with 4 nS maximal I M conductance produced a 552 significant reduction in current threshold of 26 ± 3 % (p = 0.004, two-tailed paired t-test, 553 n = 8). Conductances of 6, 8 and 10 nS resulted in average threshold reductions of 39 ± 554 4 % (p = 0.005, two-tailed paired t-test, n = 6), 60 ± 9 % (p = 0.003, two-tailed paired t-555 test, n = 6) and 63 ± 13 % (p = 0.01, two-tailed paired t-test, n = 5) respectively. One 556 cell became spontaneously active in response to substitution at 8 nS and one at 10 nS 557 (represented by a reduction of 100% in threshold in response to switching on the 558 dynamic clamp model). Taken together with the data from Figure 5C -E, these results 559 confirm that, in the family we studied, the T730A variant in Kv7.2 significantly reduces 560 the excitability of iPSC-SNs derived from subject P301 (less pain), even at the most 561 conservative estimate of maximal conductance of 4 nS. 562 563
Discussion: 564
Pain is universal but individual-to-individual differences are well documented. 565
Here we show, first, that at least in some cases, inter-individual differences in pain can 566 be modeled in a disease-in-a-dish model using subject-specific iPSC-SNs, second that 567 in some cases, mechanisms operating in peripheral sensory neurons can contribute to 568 inter-individual differences in pain, and third, we provide proof-of-concept that subject-569 specific iPSCs and WES can be used to investigate peripheral mechanisms and 570 pinpoint specific gene variants that modulate pain signaling and contribute to inter-571 individual differences in pain within a single family. 572
In this study, we demonstrate that a "pain-in-a-dish" in vitro disease model using 573 subject-specific iPSC-SNs parallels differences in pain, as reported by human subjects 574 included in this study. This iPSC-derived model revealed differences in current 575 threshold, firing frequency, responses to elevated temperature and number of 576 spontaneously active sensory neurons. Our results suggest that depolarized membrane 577 potential is a major factor responsible for the difference in excitability seen between 578 subjects P300 (more pain) and P301 (less pain) in the family under study. These data 579 demonstrate, for the first time, that in some cases inter-individual differences in chronic 580 pain can be modeled and studied in vitro. Using WES, we identified multiple candidate 581 genes (Figure 4-1) that may serve as modifiers of sensory neuron excitability in these 582 individuals. Building upon these observations we used Gene Ontology analysis to focus 583 on a variant in one gene, KCNQ2, as a candidate pain-modifier gene that might 584 contribute to inter-individual differences in pain in the family we studied, and 585 demonstrated by dynamic-clamp that a variant in KCNQ2 reduces sensory neurons 586 excitability and thus is a contributor to pain resilience in the subject with less pain. 587 In the present study we capitalized on differences in pain profiles in a unique 603 family containing two related IEM individuals (mother and son) carrying the same 604 Na V 1.7-S241T mutation (Geha et al., 2016; McDonnell et al., 2016) . This mother/son 605 pair differed markedly in terms of overall time in pain, the duration of pain attacks, and 606 the number of awakenings due to pain. The mother and son pair carried the same 607 mutation, which is known to make the DRG neurons hyperexcitable (Yang et al., 2012) , 608 but their distinct pain profiles presented an opportunity to study inter-individual 609 differences in pain within a single family, in an iPSC model. Given that Nav1.7 channels 610 are mainly expressed in the peripheral nervous system (Toledo-Aral et al., 1997; Dib-611 Hajj et al., 2013), a fundamental question was whether neurons of the peripheral 612 nervous system could contribute to differences in pain without the inclusion of a CNS 613 component. In our "pain-in-a-dish" disease model, we confirmed that subject-specific 614 iPSC-SNs generated from family members carrying a Nav1.7 mutation are more 615 excitable than neurons derived from an unaffected family member. Using this "pain-in-a-616 dish" disease model, we observed, for the first time, that an in vitro model with 617 peripheral sensory neurons alone, without a central component, can recapitulate the 618 difference in pain reported by different individuals. Although we acknowledge that CNS 619 components may still play an important role in the overall "pain experience", and our 620 study cannot rule out the involvement of central processes in modulating the pain 621 experienced by our subjects, our data indicate that the difference in pain between these 622 individuals is at least partially due to the difference in excitability of their peripheral 623 neurons. 624
In the current study, we used WES to search for putative genetic modifiers that 625 might contribute to the difference in pain in these two clinically well-studied individuals. 626
Since the present study focused on the excitability of sensory neurons, we filtered the 627 It is possible that additional gene variants, including variants with small effects, 639 may contribute to the differences we observed in excitability of iPSC-SNs derived from 640 the two subjects. We cannot rule out variations in genes not currently known to be 641 involved in neuronal excitability, which might indirectly influence peripheral neuron firing. 642
Further studies will be needed to assess the contributions of any variants of this type, 643 and to address whether epigenetic factors that influence sensory neuron firing or 644 differences in pain processing at higher levels in the CNS contribute to intrafamilial 645 variability. Importantly, we note that other gene variants might contribute to inter-646 individual differences in pain in other families. Nevertheless, our study provides proof-647 of-concept that subject-specific iPSCs and WES can be used to investigate peripheral 648 mechanisms and pinpoint specific gene variants that modulate pain signaling and 649 contribute to inter-individual differences in pain. 650
In summary, this study shows that an in vitro model of subject-specific iPSC-SNs 651 from two related subjects can recapitulate aspects of individual-to-individual differences 652 in pain, highlighting the value of studying iPSCs from individual subjects to create 653 "disease-in-a-dish" models. Our results indicate that inter-individual differences in 654 peripheral sensory neurons can, at least in some cases, contribute to differences in 655 pain, and provide proof-of-principle that it is possible to pinpoint, within a single family, a 656 specific gene that contributes to inter-individual differences in pain. -gene variants specific to subject P300 (9), P301_unique -gene variants specific to 915 subject P301 (81), P303_unique -gene variants specific to subject P303 (105). 916 
